|
45 summer interns join TGen scientists in real-life biomedical research
New test complements Castle’s DecisionDx-Melanoma gene expression profile test
LabXchange Will Provide Virtual Lab Experiences Integrating Digital Instruction With Collaboration and Mentoring Opportunities. Interactive Platform Levels Playing Field for Aspiring Scientists. Amgen Foundation Contributes $6.5 Million as Founding Sponsor
Department of Defense grant aims to target breast cancer that has spread to the bone by re-igniting the body’s own immune system.
The University of Arizona has licensed two inventions developed in the Department of Chemistry and Biochemistry to startup MCR Therapeutics. The inventors – Drs. Minying Cai and Victor J. Hruby – developed targeted peptides through their research into drug design and bioactivity expression relating to hormone activity in the brain and periphery.
From humble roots in antiquity, the scientific method has come to dominate and transform modern society. Our insights into the natural world, from bacteria to black holes, are fruits of the scientific approach to understanding, as are the life-saving medical innovations society relies on.
Innovative ‘Phase 0’ clinical trial successful in reaching deadly brain tumors
Events are planned across the nation to engage diverse communities in the national recruitment effort. In Arizona, Banner Health and the University of Arizona Health Sciences have been enrolling volunteers into the program as a National Institutes of Health pilot site since 2017.
Salutaris Medical Devices, Inc. announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018. |
